top of page
Patient on Scale

Weight Loss


‌Semaglutide acts on the body differently than insulin does. Semaglutide is a member of the GLP-1 class of drugs, and has many potential effects in the human body that affect hunger and weight. Semaglutide slows the rate at which food is transferred from the stomach to the intestines (called “gastric emptying”), which enhances the feeling of a full stomach. The drugs also pass through the bloodstream into the brain, where they act on the nervous system to decrease both food intake and appetite.

Checking Weight

Initial Evalution Includes :

  • Consultation

  • Medical History Review

  • Brief Health Exam/Systems Review

  • Weigh-in

  • Program Implementation

  • Semaglutide/B12 Prescription first 8 Weeks

Initial Evaluation


Enjoying Nature

How Does Semaglutide Work?

In large RCTs, patients receiving semaglutide, 2.4 mg, lost a mean of 6% of their weight by week 12 and 12% of their weight by week 28. Results vary, but many people start feeling the effects of the Semaglutide at the first dose and should start experiencing weight loss within the first two weeks of the program. In a 68-week trial published in the New England Journal of Medicine in March 2021, obese or overweight adults who took semaglutide had a 15% decrease on body weight, and also experienced improvements in physical function and risk factors for heart disease. 


Please make sure you fill out the intake forms 24 hours before your first visit - Brooke Carter (CRNP)

bottom of page